<DOC>
	<DOCNO>NCT00503061</DOCNO>
	<brief_summary>To investigate common patient use Symibort SMART take high average daily dos consider appropriate physician ( overuse ) hospitalise due asthma least partly due underuse .</brief_summary>
	<brief_title>A Pharmaceopidemiological Study Patients Who Use Symbicort SMART</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Budesonide , Formoterol Fumarate Drug Combination</mesh_term>
	<criteria>Asthma diagnosis , patient register prescribe physician least one year qualify prescription Symbicort , prescription Symbicort SMART UK launch concept</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>pharmaceopidemiological</keyword>
	<keyword>Symbicort SMART</keyword>
	<keyword>GPRD</keyword>
</DOC>